高危剖宫产孕妇产后出血欣母沛防治分析

The Application of Xinmupei in the Prevention and Treatment of Postpartum Hemorrhage in High-Risk Cesarean Section

目的分析高危剖宫产孕妇产后出血欣母沛防治效果.方法筛选2016年10月—2018年10月在该院进行剖宫产分娩的160例高危孕妇.按照数字随机分组法分为观察组和对照组,对照组予以缩宫素以及卡前列甲酯栓,观察组选用欣母沛进行防治,对比两组术后阴道出血情况和尿量,以及各项检查指标与临床效果.结果观察组患者于术后2 h、24 h时的阴道出血量、尿量均低于对照组;研究组孕妇术后血红蛋白水平(97.00±5.00)g/L高于对照组(84.00±4.00)g/L,差异有统计学意义(t=18.159,P<0.05).观察组产妇获得的治疗总有效率96.25%显著高于对照组82.50%,差异有统计学意义(x^2=7.964,P<0.05).结论高危剖宫产产妇应用欣母沛对产后出血进行防治,能够获得高效的防治效果,减少产后出血,保障分娩安全.

Objective To analyze the use of Xinmupei in the prevention and treatment of postpartum hemorrhage in high-risk cesarean section. Methods A total of 160 high-risk pregnant women who were given cesarean delivery in our hospital from October 2016 to October 2018 were screened. According to the numerical random grouping method, they were divided into the observation group (treated with Xinmupei) and the control group (treated with oxytocin and the cardioprostol suppository). The postoperative vaginal bleeding and urine volume were compared between the two groups. Indicators and clinical outcomes were checked. Results The vaginal bleeding volume and urine volume of the patients in the observation group were lower than those in the control group at 2 h and 24 h after operation. The hemoglobin level of pregnant women in the study group (97.00±5.00)g/L was higher than that in the control group (84.00±4.00)g/L, and there was statistically significant difference between the two groups (t=18.159, P<0.05). The total effective rate of treatment in the observation group was 96.25%, which was significantly higher than that in the control group (82.50%),the difference was statistically significant(P<0.05). Conclusion Application of Xinmupei in high-risk cesarean section maternal can prevent and treat postpartum hemorrhage, obtain effective prevention and treatment effect, reduce postpartum hemorrhage, and ensure the safety of childbirth.